Caixin App
Newsletter
Weekly Magazine
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Commentary & Analysis
Weekend Long Read
Video
ESG
Topics
China Goes Global
Asia New Vision Forum 2025
Asia New Vision Forum 2024
Selected
CX Daily
Weekly Must-Read
Caixin Briefs
Economic Indexes
Caixin Explains
News Graphics
ThinkChina
The Wall Street Journal
Podcast
Highlights
Newsletter
Events
Impact
Asia Central Banking
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
zhou xinda
China Targets Drug Over-Prescribing to Curb Insurance Fraud
China Tops World in Chronic Kidney Disease Cases, Study Shows
China Reaches ’Lower-Moderate’ TB Incidence for First Time
China Eases Drug Procurement Rules, Keeps Winning Bids Secret
China’s Retirement Preparedness Lags as Youth Eye Early Exit, Report Says
In Depth: Lawsuits Lay Bare Shortcomings of China’s Commercial Insurers
Chinese Official Who Led Antifraud Probes Investigated for Corruption
Analysis: China’s Pension Puzzle — Why Some Retirees Make More Than Active Workers
In Depth: New Innovative Drug List Could Expand Access to Costly Breakthroughs
Two Chinese Medical-Device Makers Declare Bankruptcy After Winning Bulk-Buying Bids
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通